BioLife Solutions Inc (BLFS)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	-13,096	-27,637	-41,553	-49,386	-52,863	-88,979	-85,244	-151,179	-145,541	-114,735	-114,154	-42,146	-35,160	-22,104	-12,191	-7,592	-6,241	-1,593	-1,119	-416
Revenue (ttm)	US$ in thousands	102,868	122,972	125,729	136,909	142,796	154,008	161,427	162,452	161,032	154,468	147,521	138,192	118,837	96,581	74,057	52,773	48,087	41,249	36,673	33,590
Operating profit margin		-12.73%	-22.47%	-33.05%	-36.07%	-37.02%	-57.78%	-52.81%	-93.06%	-90.38%	-74.28%	-77.38%	-30.50%	-29.59%	-22.89%	-16.46%	-14.39%	-12.98%	-3.86%	-3.05%	-1.24%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-13,096K ÷ $102,868K
= -12.73%

The operating profit margin of BioLife Solutions Inc has exhibited a declining trend from March 31, 2020, to December 31, 2024. The company's margin started at -1.24% in March 2020 and progressively worsened, reaching its lowest point at -93.06% in March 2023.

During the subsequent periods, there was a fluctuation in the operating profit margin, with some improvement seen in the latter half of 2024, where the margin improved to -12.73% by December 31, 2024.

The overall trajectory suggests that BioLife Solutions Inc has faced challenges in generating sufficient operating profits relative to its revenue during this period. The company may need to focus on improving operational efficiency, cost management, and revenue generation strategies to enhance its profitability in the future.